What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies. (2019)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/mbc.0000000000000789
PubMed Identifier: 30585835
Publication URI: http://europepmc.org/abstract/MED/30585835
Type: Journal Article/Review
Volume: 30
Parent Publication: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Issue: 1
ISSN: 0957-5235